Immunodiagnostic Systems Hldgs PLC Company Profile (LON:IDH)

Analyst Ratings

Consensus Ratings for Immunodiagnostic Systems Hldgs PLC (LON:IDH) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2015N+1 SingerReiterated RatingSellGBX 294View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015Canaccord GenuityReiterated RatingSellGBX 280View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015Panmure GordonReiterated RatingSellGBX 270View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014FinnCapReiterated RatingUnder ReviewView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/22/2016GBX 1.200.94%7/21/20167/21/20168/19/2016Tweet This Announcement  Share This Announcement on StockTwits
6/23/2015GBX 31.03%7/23/20157/23/20158/21/2015Tweet This Announcement  Share This Announcement on StockTwits
6/24/2014GBX 8.501.57%7/23/20147/23/20148/22/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/8/2016Kaspar,Klaus PeterInsiderBuy4,100GBX 142£5,822Tweet This Trade  Share This Trade on StockTwits
7/1/2016Kaspar,Klaus PeterInsiderBuy5,000GBX 138£6,900Tweet This Trade  Share This Trade on StockTwits
6/30/2016Kaspar,Klaus PeterInsiderBuy6,000GBX 137£8,220Tweet This Trade  Share This Trade on StockTwits
6/27/2016Lacalle,PatricioInsiderBuy17,258GBX 138£23,816.04Tweet This Trade  Share This Trade on StockTwits
6/23/2016Martin,Paul JamesInsiderBuy10,000GBX 132£13,200Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Immunodiagnostic Systems Hldgs PLC (LON:IDH)
DateHeadline
07/28/16 04:43 PMManagement 'working hard' to reverse revenue decline at Immunodiagnostic Systems Holdings
07/28/16 04:43 PMImmunodiagnostic Systems Hldgs : Working To Return To Growth As Quarterly Revenue Down
07/21/16 10:36 AMIMMUNODIAGNOSTIC SYSTEMS HLDGS PLC : ex-dividend day for annual dividend
07/06/16 09:14 AMDIRECTOR DEALINGS SUMMARY: ECO Animal Health Founder Sells Shares
07/06/16 09:14 AMDIRECTOR DEALINGS: Immunodiagnostic Systems Non-Executive Buys Shares
06/28/16 09:29 AMDIRECTOR DEALINGS: Immunodiagnostic Chief Executive Buys First Shares
06/27/16 04:34 PMCancer Testing/Screening Market - Technological Advancements & Developments Driving Growth - Research and Markets
06/23/16 04:54 PMDIRECTOR DEALINGS: Immunodiagnostic Finance Boss Buys First Shares
06/22/16 09:14 AMDirectors at North East life sciences firm upbeat despite 15% slump in sales
06/22/16 09:14 AMImmunodiagnostic Systems Hldgs : Swings To Loss On Impairment Charges
06/22/16 09:14 AMImmunodiagnostic Systems Holdings ( IDH )
06/17/16 04:29 PMImmunodiagnostic Systems Hldgs PLC : annual earnings release
02/03/16 11:31 AMCommercial addition - 18.01.2016 Klaus Peter Kaspar joined the board of Immunodiagnostic Systems Holdings plc in December. The biochemist has more than 35 years of experience in the field of diagnostics. From 2005 to 2011, Kaspar worked at bioMérieux, where he held the ...
01/31/16 10:51 AMAudit Committee of Immunodiagnostic Systems Holdings plc - Member of Remuneration Committee and Member of Nominations Committee Immunodiagnostic Systems Holdings plc Appoints Klaus Kaspar as Non-Executive Director Peter Williamson 6 Relationships Non-Executive Director, Member of Audit Committee, Member of ...
01/18/16 10:06 AMExperience on board - 18.01.2016 - Klaus Peter Kaspar joined to board of Immunodiagnostic Systems Holdings plc in December. The biochemist has more than 35 years of experience in the field of diagnostics. From 2005 to 2011, Kaspar worked at bioMérieux, where he held the ...
12/18/15 09:25 AMImmunodiagnostic Systems Holdings Plc – Value Analysis (LONDON:IDH) : December 18, 2015 -

Social

About Immunodiagnostic Systems Hldgs PLC

Immunodiagnostic Systems Hldgs PLC logoImmunodiagnostic Systems Holdings PLC is a solution provider for specialty testing in immunodiagnostics. Through its subsidiaries, the Company is also engaged in developing, manufacturing and distributing medical diagnostic products; manufacturing diagnostic test kits, and developing, manufacturing and distributing automated instruments and the distribution of its products in France and Belgium. The Company offers IDS-iSYS instrument platform is an instrument based on Chemiluminescence and Absorbency technology. The Company's IDS-iSYS platform is focused on a range of clinical areas, including bone metabolism, calcium metabolism, hypertension, chronic kidney disease and growth. The Company's subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Inc, Immunodiagnostic Systems Deutschland GmbH, Suomen Bioanalytiikka Oy (SBA Sciences Ltd), Immunodiagnostic Systems Nordic A/S, Immunodiagnostic Systems SA, ImmunoDiagnostic Systems France SAS and MGP Diagnostics AS.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: IDH
  • CUSIP:
Key Metrics:
  • Previous Close: $1.97
  • 50 Day Moving Average: $138.15
  • 200 Day Moving Average: $183.34
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $43.68M
  • Current Year EPS Consensus Estimate: $8.50 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: